Revolutionizing ALS Treatment: The Tofersen Breakthrough
Dr. Gordon Smith and Dr. Timothy Miller discuss compelling clinical data suggesting that ALS may be a treatable disease for a subset of patients.
Read the full articleYou might also wanna read
Neurologist explains new drug combination for patients with ALS
Interview with Upstate neurologist Jenny Meyer, MD
Pouring cold water on ALS progression: novel drug shields neurons from damage
Original story from the University of Arizona (AZ, USA). An experimental drug that targets the TDP-43 protein offers hope for treating Amyot
New Alzheimer’s Breakthrough Targets Disease at the Cellular Level, Shows Promise
A Boston biotech firm has unveiled a first-of-its-kind treatment targeting the root causes of Alzheimer’s using brain organoids, Tau biomark
A positive outlook for multiple sclerosis; new birth control option; preventing kidney stones: Upstate Medical University's HealthLink on Air for Sunday, Nov. 7, 2021
Interviews with neurologist Corey McGraw, MD, gynecologist Renee Mestad, MD, and urologist Scott Wiener, MD
AI accelerates search for motor neurone disease treatments by repurposing existing drugs
Researchers hope the work will help identify affordable, effective drugs to treat conditions like MND.
bbc.co.uk·1mo agoThe BANYAN Trial, an ALS MyMatch Trial Evaluating Safety, Biomarker Activity, and Microglial Activation of Nasal Foralumab
Conditions : ALS (Amyotrophic Lateral Sclerosis); ALS - Amyotrophic Lateral Sclerosis; ALS Interventions : Drug: Foralumab Nasal; Drug: Plac
Comments
Sign in to join the conversation.
No comments yet. Be the first.